A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination
about
A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2017
@uk
name
A screen for combination thera ...... r as a synergistic combination
@en
A screen for combination thera ...... r as a synergistic combination
@nl
type
label
A screen for combination thera ...... r as a synergistic combination
@en
A screen for combination thera ...... r as a synergistic combination
@nl
prefLabel
A screen for combination thera ...... r as a synergistic combination
@en
A screen for combination thera ...... r as a synergistic combination
@nl
P2093
P50
P356
P1476
A screen for combination thera ...... r as a synergistic combination
@en
P2093
Aida Shahrabi
Clara Alsinet
Daniel Peeper
David J Adams
David Tamborero
Emmanuelle Supper
Fiona Behan
Gemma Turner
Graham R Bignell
P356
10.1101/195354
P50
P577
2017-09-28T00:00:00Z